Multinational healthcare provider IHH Healthcare ("IHH" or the "Group") has announced its new Global Incubator Programme, a significant step towards empowering early-stage startups to develop groundbreaking healthcare solutions that could potentially revolutionize the industry.
"Through this Global Incubator Programme, we are expanding our innovation drive to support early-stage healthcare innovators, empowering them to develop solutions that can transform patient care," Ashok Pandit, group chief corporate officer, IHH Healthcare.
Global Incubator Programme
The three-month cycles of the Global Incubator Programme offer selected healthcare startups a comprehensive support system, including mentorship from IHH leadership and clinicians, collaboration opportunities , resources and infrastructure, and scaling pathways through potential partnerships across IHH's global network.
Funding innovative ideas
IHH's Innovation Fund, Research Grant, and Innovation Sandbox may also grant funding to successful startups.
An SGD80 million Innovation Fund aims to invest in startups developing novel and cutting-edge healthcare technologies.
IHH also launched a SGD5 million Research Grant & Innovation Sandbox programme to empower IHH clinicians and employees to pursue clinical research and pilot innovative ideas for the healthcare industry.
APAC Innovation showcase
Some innovations showcased by IHH in the Asia Pacific region are the following:
Malaysia:
- Premier Integrated Labs introduced PathoInsight-Tan AI tool for cervical cancer screening in
- Gleneagles Hospital Johor is the first hospital in Malaysia to use AI for the detection of anomalies in chest and brain imaging.
Singapore:
- Lucence has enhanced early cancer screening and supports clinicians in selecting optimal treatments with advanced therapy technology.
- IHH Singapore pioneered an AI-powered nurse rostering tool, NurseShift.ai
